Only increase if lower doses plateau and you tolerate well
Fact: High doses mean very little if the delivery system is poor
Current UK regulatory position includes: Warnings and precautions regarding thyroid C-cell tumours based on animal data, with acknowledgement that human relevance is uncertain Advice regarding pancreatitis risk, with recommendations to discontinue if acute pancreatitis is suspected and not to restart if confirmed No restrictions based on general cancer risk, as human evidence does not support an increased overall malignancy risk Monitoring for gallbladder disease, which has been associated with GLP-1 receptor agonist use The Summary of Product Characteristics (SmPC) for each GLP-1 medicine includes detailed safety information that healthcare professionals should review before prescribing
Rac1(PMN) and Rac1(PBMC) had the most significant impact on identifying E
essentially the immune systems mistakenly recognises pancreatic beta cells (The cells that release insulin in your body) as a foreign substance/organism, and therefore must be removed/killed from the body
People go to you go to a primary care physician, you go to an endocrinologist, they go to a cardiologist